Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening (Clinical Trial Not Allowed)
National Institutes of Health · Department of Health and Human Services · RFA-TR-25-016
In plain English
National Institutes of Health (Department of Health and Human Services) has announced this as a forecast: an opportunity it expects to post. It is not open for applications yet. Estimated posting date: Jan 16, 2026 (this estimate has passed and the agency has not posted it yet). Estimated application due date: Jun 16, 2026.
The agency expects to make 2 awards and estimated total program funding is $1,600,000.
Eligible applicant types include nonprofits, small businesses, for-profit companies, state governments, local governments, tribal governments & organizations, colleges & universities, school districts and public housing authorities, plus others described in the listing.
The listing says cost sharing or matching is not required.
Built only from the fields in the Grants.gov listing. Always confirm on the official listing.
Key facts
| Status | Forecasted: not open yet |
|---|---|
| Estimated posting date | Jan 16, 2026 (estimate has passed) |
| Estimated application due date | Jun 16, 2026 |
| Estimated award date | Apr 15, 2027 |
| Estimated project start | Apr 15, 2027 |
| Fiscal year | 2027 |
| Forecast posted | Sep 29, 2025 |
| Opportunity number | RFA-TR-25-016 |
| Agency | National Institutes of Health (Department of Health and Human Services) |
| Funding instrument | Cooperative agreement |
| Category | Health |
| Opportunity category | Discretionary |
| Award ceiling (max per award) | Not stated |
| Award floor (min per award) | Not stated |
| Estimated total program funding | $1,600,000 |
| Expected number of awards | 2 |
| Cost sharing or matching required | No |
| Assistance listing (CFDA/ALN) | 93.350 – National Center for Advancing Translational Sciences |
| Last updated on Grants.gov | Sep 29, 2025 |
Who can apply
Browse similar: Nonprofits · Small businesses · For-profit companies · State governments · Local governments · Tribal governments & organizations · Colleges & universities · School districts · Public housing authorities
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Native American tribal governments (federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than federally recognized tribal governments)
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others (see the eligibility details in the listing)
Additional eligibility information (excerpt from the listing):
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-Eligible ApplicantsNon-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Description
Excerpt from the official forecast on Grants.gov (shortened; read the full text on the official listing):
NIH intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that will develop, validate and demonstrate the utility of advanced 3-D tissue models for testing the efficacy of various therapeutic modalities, including small molecules and biologics and accelerate the discovery and development of new therapeutics across different diseases. The initiative will develop advanced 3-D drug screening models adaptable to high throughput assays. These non-animal models are expected to mimic structural, biochemical and mechanical properties of tissue that are representative of a drug’s behavior in a body, resulting in improved predictive accuracy. This is an expansion upon the work conducted under previous NOFOs, RFA-TR-17-007, RFA-TR-19-020 and RFA-TR-21-015, that have focused on development of 3-D skin and other tissue models for drug screening. …
More Department of Health and Human Services grants closing soon
All →- 2days leftNCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
More health grants closing soon
All →- 5days leftEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
- 6days leftSingle Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 6days leftPrevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 6days leftFeasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth